🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the response rate and to...
Status
Completed
Location
Hôpital Saint-Louis
Start Date
2005-01
Trial ID
NCT00169468
Treatments Being Tested
Evaluation of the safety and effectiveness of metformin as an adjunct to RC...
Status
Completed
Location
Hospital Universitario Dr. José Eleuterio González
Start Date
2017-10-01
Trial ID
NCT03200015
Treatments Being Tested
Patients treated for DLBCL are at high risk of developing AICD. This advers...
Status
Recruiting
Location
NL-Den Bosch-JBZ
Start Date
2024-08-15
Trial ID
NCT06220032
The primary objective of the study is to assess the efficiency of SCT400 pl...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2016-06
Trial ID
NCT02772822
Treatments Being Tested
This phase II trial studies how well obinutuzumab with or without umbralisi...
Status
Active Not Recruiting
Location
Alaska Breast Care and Surgery LLC
Start Date
2018-01-23
Trial ID
NCT03269669
This study aims; to assess the efficacy of shortened systemic chemotherapy ...
Status
Unknown
Location
Asan Medical Center
Start Date
2010-08
Trial ID
NCT01279902
Treatments Being Tested
Multi-center retrospective analysis of patients with DLBCL aged ≥80 years o...
Status
Completed
Location
Saarland University Medical Center
Start Date
2018-07-01
Trial ID
NCT06150053
This study evaluates the addition of Acalabrutinib to current standard ther...
Status
Active Not Recruiting
Location
Colchester General Hospital
Start Date
2021-10-19
Trial ID
NCT04546620
Treatments Being Tested
This study is a phase II clinical trial and is divided into three stages. ...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-30
Trial ID
NCT07538180
Treatments Being Tested
This study is a multi-center, open-label, single-arm, non-randomized phase ...
Status
Unknown
Location
Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
Start Date
2022-02-01
Trial ID
NCT05200312